3121 - 3130 of 6560 Results
Title
Year
-
OPENTitle: Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 2039End Page: 2040Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25637Best OA location URL: http://doi.org/10.1002/mds.25637Citation Count: 9
-
OPENTitle: Metabolomics and the search for biomarkers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1620End Page: 1621Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25644Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4050667Citation Count: 11
- β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia2012OPENTitle: β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementiaJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 296End Page: 301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25213Best OA location URL: https://hdl.handle.net/2027.42/97160Citation Count: 96
-
OPENTitle: Measuring mild cognitive impairment in patients with Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 5Start Page: 626End Page: 633Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25426Best OA location URL: http://doi.org/10.1002/mds.25426Citation Count: 145
-
OPENTitle: Heterogeneity in primary dystonia: Lessons from THAP1, GNAL, and TOR1A in Amish‐MennonitesJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 812End Page: 818Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25818Best OA location URL: http://doi.org/10.1002/mds.25818Citation Count: 38
-
OPENTitle: Results of the citalopram to enhance cognition in Huntington disease trialJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 3Start Page: 401End Page: 405Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25750Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3960314Citation Count: 65
-
OPENTitle: Evaluation of mild cognitive impairment subtypes in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 756End Page: 764Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25875Best OA location URL: http://doi.org/10.1002/mds.25875Citation Count: 63
-
OPENTitle: Parkinson's disease, cortical dysfunction, and alpha‐synucleinJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1436End Page: 1442Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23697Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3154995Citation Count: 25
-
OPENTitle: Sham surgery controls in Parkinson's disease clinical trials: Views of participantsJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 11Start Page: 1461End Page: 1465Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25155Best OA location URL: https://hdl.handle.net/2027.42/93771Citation Count: 24
- Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study2011OPENTitle: Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker StudyJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2283End Page: 2286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23934Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3337217Citation Count: 25